Cheryl Vendemia

Cheryl Vendemia serves as a key procurement professional within the Naval Medical Logistics Command (N62645), supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of advanced diagnostic, life-sustaining, and point-of-care medical systems. She manages a diverse portfolio of contracts focused on research and development, analytical instrumentation, and in-vitro diagnostic manufacturing, ensuring that Navy and Marine Corps medical units are equipped with cutting-edge technologies for battlefield care and preventive medicine. Her acquisitions are strategically aligned with modernization priorities, emphasizing rapid deployment, field durability, and interoperability with existing clinical platforms. While specific contractor relationships are not publicly detailed, Vendemia’s procurement patterns indicate engagement with a broad spectrum of technical suppliers, including firms specializing in laboratory instrument manufacturing, diagnostic substance production, and biomedical R&D services. Her contracting approach favors established defense and healthcare technology vendors with proven capabilities in military-grade compliance, quality systems (ISO 13485), and rapid supply chain responsiveness under austere conditions. Vendemia’s contracting activity reflects a strong preference for open competition, with 97.1% of awards issued without set-aside restrictions, indicating a focus on technical merit and mission-critical capability over socioeconomic classifications. However, she maintains a measured commitment to small business participation, with approximately 2.9% of awards designated as total small business set-asides under FAR 19.5, demonstrating alignment with DoD’s broader goals for innovation and vendor diversity. Her primary industry focus lies in NAICS 541715, reflecting deep expertise in physical and engineering research and development for medical applications. She frequently procures analytical laboratory instruments, in-vitro diagnostic reagents, and specialized diagnostic equipment, underscoring her technical proficiency in clinical diagnostics, biomedical engineering, and field-deployable medical technology. Her work directly enables the Navy’s capacity to deliver advanced care in expeditionary and global operational environments.